| 新加坡新型冠状病毒疫苗免疫接种策略研究 |
| |
| 引用本文： | 伊赫亚,赵秸米,梁晓峰,Teo Yik Ying.新加坡新型冠状病毒疫苗免疫接种策略研究[J].中华流行病学杂志,2022,43(3):310-314. |
| |
| 作者姓名： | 伊赫亚 赵秸米 梁晓峰 Teo Yik Ying |
| |
| 作者单位： | 中华预防医学会;新加坡国立大学 |
| |
| 基金项目： | 2021年中国科协“一带一路”国际科技组织合作平台建设项目（2021ZZGJB0522） |
| |
| 摘 要： | 截至2021年12月31日，新加坡累计报告已有4 758 601人完成至少一剂次新型冠状（新冠）病毒疫苗接种，4 714 655人完成两剂次新冠病毒疫苗接种，2 207 341人完成新冠病毒疫苗加强针接种。本研究通过深入分析新加坡新冠病毒疫苗接种现状，解读新加坡国家疫苗接种计划内容，系统梳理新加坡新冠病毒疫苗上门接种、...
|
| 关 键 词： | 新型冠状病毒 免疫接种 防控措施 新加坡 |
| 收稿时间： | 2021/11/25 0:00:00 |
Research on COVID-19 vaccination strategies in Singapore |
| |
| Yi Hey,Zhao Jiemi,Liang Xiaofeng,Teo Yik Ying.Research on COVID-19 vaccination strategies in Singapore[J].Chinese Journal of Epidemiology,2022,43(3):310-314. |
| |
| Authors: | Yi Hey Zhao Jiemi Liang Xiaofeng Teo Yik Ying |
| |
| Institution: | Chinese Preventive Medicine Association, Beijing 100021, China;Chinese Preventive Medicine Association, Beijing 100021, China;Kangtai Biological Vaccine Industry Research Institute, Jinan University, Guangzhou 510632, China; National University of Singapore, Singapore City 119077, Singapore |
| |
| Abstract: | As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore''s National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China. |
| |
| Keywords: | 2019-nCoV Vaccination Prevention and control Singapore |
|
| 点击此处可从《中华流行病学杂志》浏览原始摘要信息 |
| 点击此处可从《中华流行病学杂志》下载免费的PDF全文 |
|
